Impact of Patient Reminders on Papanicolaou Test Completion for High-Risk Patients Identified by a Clinical Decision Support System.
Impact of Patient Reminders on Papanicolaou Test Completion for High-Risk Patients Identified by a Clinical Decision Support System.
复制标题
DOI:
10.1089/jwh.2017.6667
复制
发表时间:
2018-05
期刊:
影响因子:
--
通讯作者:
Chaudhry R
中科院分区:
文献类型:
--
作者:
MacLaughlin KL;Kessler ME;Komandur Elayavilli R;Hickey BC;Scheitel MR;Wagholikar KB;Liu H;Kremers WK;Chaudhry R
Background: A clinical decision support system (CDSS) for cervical cancer screening identifies patients due for routine cervical cancer screening. Yet, high-risk patients who require more frequent screening or earlier follow-up to address past abnormal results are not identified. We aimed to assess the effect of a complex CDSS, incorporating national guidelines for high-risk patient screening and abnormal result management, its implementation to identify patients overdue for testing, and the outcome of sending a targeted recommendation for follow-up. Materials and Methods: At three primary care clinics affiliated with an academic medical center, a reminder recommending an appointment for Papanicolaou (Pap) testing or Pap and human papillomavirus cotesting was sent to high-risk women aged 18 through 65 years (intervention group) identified by CDSS as overdue for testing. Historical control patients, who did not receive a reminder, were identified by CDSS 1 year before the date when reminders were sent to the intervention group. Test completion rates were compared between the intervention and control groups through a generalized estimating equation extension. Results: Across the three sites, the average completion rate of recommended follow-up testing was significantly higher in the intervention group at 23.7% (61/257) than the completion rate at 3.3% (17/516) in the control group (p < 0.001). Conclusions: A CDSS with enhanced capabilities to identify high-risk women due for cervical cancer testing beyond routine screening intervals, with subsequent patient notification, has the potential to decrease cervical precancer and cancer by improving adherence to guideline-compliant follow-up and needed treatment.
登录
查看更多内容
DOI:
10.1136/amiajnl-2012-000820
发表时间:
2012-09
期刊:
Journal of the American Medical Informatics Association : JAMIA
影响因子:
--
作者:
Wagholikar KB;MacLaughlin KL;Henry MR;Greenes RA;Hankey RA;Liu H;Chaudhry R
通讯作者:
Chaudhry R
影响因子:
12.7
作者:
JANERICH, DT;HADJIMICHAEL, O;POLEDNAK, AP
通讯作者:
POLEDNAK, AP
影响因子:
7.2
作者:
Massad, L. Stewart;Einstein, Mark H.;Lawson, Herschel W.
通讯作者:
Lawson, Herschel W.
DOI:
10.1136/amiajnl-2013-001613
发表时间:
2013-07
期刊:
Journal of the American Medical Informatics Association : JAMIA
影响因子:
--
作者:
Wagholikar KB;MacLaughlin KL;Kastner TM;Casey PM;Henry M;Greenes RA;Liu H;Chaudhry R
通讯作者:
Chaudhry R
影响因子:
3.7
作者:
Duggan, Maire A.;Nation, Jill
通讯作者:
Nation, Jill